Comparison of CE-FDG-PET/CT with CE-FDG-PET/MR in the evaluation of osseous metastases in breast cancer patients

BACKGROUND: Despite improvements in treatments, metastatic breast cancer remains difficult to cure. Bones constitute the most common site of first-time recurrence, occurring in 40–75% of cases. Therefore, evaluation for possible osseous metastases is crucial. Technetium 99 ((99)Tc) bone scintigraphy...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Br J Cancer
Autors principals: Catalano, O A, Nicolai, E, Rosen, B R, Luongo, A, Catalano, M, Iannace, C, Guimaraes, A, Vangel, M G, Mahmood, U, Soricelli, A, Salvatore, M
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2015
Matèries:
Clinical Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4453670/
https://ncbi.nlm.nih.gov/pubmed/25871331
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2015.112
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars